XML 33 R25.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment Reporting (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting [Abstract] |
Summary of Disaggregated Segment Expenses Split between R&D and G&A Costs | The following table presents the significant segment expenses for the three months ended March 31, 2026 and 2025 (in thousands):
|  | Three Months Ended |
|  | March 31, |
|  | 2026 |  |  | 2025 |
Research and development expenses: |  |  |  |  |  |
Clinical and development costs |  | $ | 8,280 |  |  | $ | 10,537 |
Preclinical costs |  |  | (65 | ) |  |  | 1,238 |
Personnel and related costs |  |  | 3,175 |  |  |  | 7,563 |
Stock-based compensation expense |  |  | 1,201 |  |  |  | 3,005 |
Other research costs |  |  | 1,015 |  |  |  | 1,545 |
Total research and development expenses |  |  | 13,606 |  |  |  | 23,888 |
General and administrative expenses: |  |  |  |  |  |
Personnel and related costs |  |  | 1,841 |  |  |  | 2,825 |
Stock-based compensation expense |  |  | 1,308 |  |  |  | 2,211 |
Other general and administrative costs |  |  | 2,211 |  |  |  | 2,896 |
Total general and administrative expenses |  |  | 5,360 |  |  |  | 7,932 |
Loss from operations |  |  | (18,966 | ) |  |  | (31,820 | )
Interest income |  |  | 1,182 |  |  |  | 1,483 |
Interest expense |  |  | (331 | ) |  |  | (406 | )
Other income (expense), net |  |  | 188 |  |  |  | (11 | )
Net loss |  | $ | (17,927 | ) |  | $ | (30,754 | )

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration